PRLD
PRLD
NASDAQ · Biotechnology

Prelude Therapeutics Inc

$3.60
+0.05 (+1.27%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +161.7% upside
Low Target $6.99
Average Target $9.42
High Target $10.52
Current Price $3.60
Current
$3.60
Target
$9.42
$6.99 $9.42 avg $10.52
Scenario Analysis
Bear Case
$6.99
94.2%
Low target
Base Case
$9.42
+161.7%
Avg target
Bull Case
$10.52
+192.2%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$6.83
-47.3% from high
52-Week Low
$1.17
+206.9% from low
Target vs 52W High
$9.42
+37.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%